News

Researchers performed a nationwide cohort study of the use of calcium-channel blockers and adenosine modulators and risk of hospitalization in bipolar disorder.

Here’s why educators are walking away from the profession they love.

"With our country’s ongoing mental health and addiction crisis, the consequences of the Wit v UBH reversal are too great to ignore."

Reflections on the bounty of life...

Classic psychedelic research is rapidly expanding...

College mental health: on the decline for at least 8 years.

Missing out on treating a person rather than a diagnosis?

The 18 hours a day, 7 days a week doctor lifestyle is over. But it’s not the cause of the burnout epidemic…

A psychiatrist reflects on trauma, healing, and growth...

From older age bipolar disorder to the relationship between antidepressants and emotional numbing, here are highlights from the week in Psychiatric Times.

What treatments are available for those with older age bipolar disorder?

Is jazz a good litmus test for Russia’s leadership?

What is a safety plan, and how can clinicians use it to help patients with suicidal behavior?

It could be a long and cold winter for Russia…

The experts weighed in on a wide variety of psychiatric issues for the September 2022 issue of Psychiatric Times.

Between 1980 and 1998, the relative frequency of late-onset bipolar disorder increased from 1% to 11%. How can you best assess for this condition?

Here’s how the American Psychiatric Association and the American Academy of Psychiatry and the Law provide valuable opportunities for psychiatrists and the psychiatric field.

Should religion and spirituality be tools in the psychiatric arsenal?

As patients improve with antidepressant treatment, emotional numbing decreases.

In a well-blinded study, researchers investigated and directly compared the acute effects of LSD and psilocybin in healthy participants.

Stigma poses a serious risk to quality of care and accessibility.

This jazz musician, in his own way, helped improve mental health.

A new—cough, cough—combination treatment for depression. Researchers performed an RCT of dextromethorphan-bupropion in major depressive disorder.

From historic USPSTF draft screening recommendations to the need for novel treatments for bipolar depression, here are highlights from the week in Psychiatric Times.

How can a robust understanding of the altered-state experience drive the development of therapeutic frameworks that are designed around that experience?

The sources of chronic stress and inflammation need to change, which means the toxic work setting needs to change.

This book provides a comprehensive overview of the most sustained comprehensive mental health recovery and research program implemented after a natural disaster.

Only we have the power to permanently increase our lightness over dark.